Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Berman

Showing results (351-360 of 381) with videos related to

Pageof 39
Sort By:
Brain Communications|October 23, 2024
Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's diseaseLisa Vermunt, Courtney L Sutphen, Ellen Dicks, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical TrialsH Liu, J Li, E Ziegemeier, et al.
Medrxiv : the Preprint Server for Health Sciences|April 5, 2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer diseaseL Vermunt, C Sutphen, E Dicks, et al.
NPJ Dementia|February 19, 2026
15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
The Lancet. Neurology|February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal studyBrian A Gordon, Tyler M Blazey, Yi Su, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 24, 2022
Pattern and implications of neurological examination findings in autosomal dominant Alzheimer diseaseJonathan Vöglein, Nicolai Franzmeier, John C Morris, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
Brain Communications|November 9, 2023
Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's diseaseJorge J Llibre-Guerra, Leonardo Iaccarino, Dean Coble, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Pageof 39

Showing results (351-360 of 381) with videos related to

Sort By:
Pageof 39
Brain Communications|October 23, 2024
Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's diseaseLisa Vermunt, Courtney L Sutphen, Ellen Dicks, et al.
The Journal of Prevention of Alzheimer'S Disease|May 6, 2024
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical TrialsH Liu, J Li, E Ziegemeier, et al.
Medrxiv : the Preprint Server for Health Sciences|April 5, 2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer diseaseL Vermunt, C Sutphen, E Dicks, et al.
NPJ Dementia|February 19, 2026
15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
The Lancet. Neurology|February 5, 2018
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal studyBrian A Gordon, Tyler M Blazey, Yi Su, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 24, 2022
Pattern and implications of neurological examination findings in autosomal dominant Alzheimer diseaseJonathan Vöglein, Nicolai Franzmeier, John C Morris, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
Brain Communications|November 9, 2023
Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's diseaseJorge J Llibre-Guerra, Leonardo Iaccarino, Dean Coble, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Pageof 39